Evidence map›Paper›PMID 38200290›Full record

ReviewMolecular psychiatry2024

Psychosis superspectrum I: Nosology, etiology, and lifespan development.

Katherine G Jonas, Tyrone D Cannon, Anna R Docherty, Dominic Dwyer, Ruben C Gur, Raquel E Gur, Barnaby Nelson, Ulrich Reininghaus, Roman Kotov

Abstract readReview
In one paragraph

Review in Molecular psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Auditory event-related potentials and psychosis dimensions.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Schizophrenia.Nature reviews. Disease primers · 2025
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Katherine G JonasDepartment of Psychiatry & Behavioral Health, Stony Brook University, Stony Brook, NY, USA. Katherine.jonas@stonybrookmedicine.edu.ORCID 0000-0002-1910-223X
Tyrone D CannonDepartment of Psychology, Yale University, New Haven, CT, USA.ORCID 0000-0002-5632-3154
Anna R DochertyHuntsman Mental Health Institute, Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT, USA.ORCID 0000-0001-7139-7007
Dominic DwyerDepartment of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany.ORCID 0000-0003-3949-5867
Ruben C GurBrain Behavior Laboratory, Department of Psychiatry and the Penn-CHOP Lifespan Brain Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.ORCID 0000-0002-4082-8502
Raquel E GurBrain Behavior Laboratory, Department of Psychiatry and the Penn-CHOP Lifespan Brain Institute, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Barnaby NelsonCentre for Youth Mental Health, University of Melbourne, Melbourne, VIC, Australia.
Ulrich ReininghausDepartment of Public Mental Health, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Roman KotovDepartment of Psychiatry & Behavioral Health, Stony Brook University, Stony Brook, NY, USA.

Funding

Genome-Wide Association Analysis of Suicide DeathR01MH123619 · NIMH · UNIVERSITY OF UTAH · PI DOCHERTY, ANNA R. · 2020 to 2024
$3.2M
Spanish Adaptation of Negative Valence MeasuresR01MH122537 · NIMH · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI KOTOV, ROMAN I, SIMMS, LEONARD JAY · 2021 to 2024
$3.1M
Trajectories and Determinants of Cognitive Decline in Psychotic Disorders Over 35 YearsR01MH135119 · NIMH · STATE UNIVERSITY NEW YORK STONY BROOK · PI Katherine G Jonas, Roman I Kotov · 2024 to 2026
$2.3M
Improving the Precision of Genetic Markers for Psychotic DisordersK08MH122673 · NIMH · STATE UNIVERSITY NEW YORK STONY BROOK · PI JONAS, KATHERINE G · 2020 to 2023
$782k
Optimized Phenotypes for Genetic Association StudiesR21MH123908 · NIMH · STATE UNIVERSITY NEW YORK STONY BROOK · PI JONAS, KATHERINE G · 2020 to 2020
$448k
NIMH NIH HHS K08 MH122673NIMH NIH HHS R01 MH122537NIMH NIH HHS R01 MH123619NIMH NIH HHS R01 MH135119NIMH NIH HHS R21 MH123908U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R01MH122537U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R21MH123908
6 · The paper itself

Abstract

This review describes the Hierarchical Taxonomy of Psychopathology (HiTOP) model of psychosis-related psychopathology, the psychosis superspectrum. The HiTOP psychosis superspectrum was developed to address shortcomings of traditional diagnoses for psychotic disorders and related conditions including low reliability, arbitrary boundaries between psychopathology and normality, high symptom co-occurrence, and heterogeneity within diagnostic categories. The psychosis superspectrum is a transdiagnostic dimensional model comprising two spectra-psychoticism and detachment-which are in turn broken down into fourteen narrow components, and two auxiliary domains-cognition and functional impairment. The structure of the spectra and their components are shown to parallel the genetic structure of psychosis and related traits. Psychoticism and detachment have distinct patterns of association with urbanicity, migrant and ethnic minority status, childhood adversity, and cannabis use. The superspectrum also provides a useful model for describing the emergence and course of psychosis, as components of the superspectrum are relatively stable over time. Changes in psychoticism predict the onset of psychosis-related psychopathology, whereas changes in detachment and cognition define later course. Implications of the superspectrum for genetic, socio-environmental, and longitudinal research are discussed. A companion review focuses on neurobiology, treatment response, and clinical utility of the superspectrum, and future research directions.

Indexed as

Psychotic DisordersHumansLongevityPsychopathology

Identifiers

PMID38200290
PMCPMC11385553

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.